Imricor Medical Systems announced that it commenced a trial by completing its first-in-human ventricular ablation procedure.

The US FDA has approved EBR System's leadless pacemaker WISE, the only heart device able to deliver left-ventricle ...

The following is a summary of "Novel Right Ventricular Function Parameters Can Identify Short-Term Non-Responders To ...

SELF-ADMINISTERED etripamil, an intranasal calcium channel blocker, significantly reduces emergency department (ED) visits ...

At four-years old little Mia Dearness is full of energy and life, a stark contrast to when she was born with childhood-onset ...

Imricor receives CE Mark certification for the Advantage-MR system under new European Medical Device Regulation as it hits ...

Participants who walked faster were more likely to be men, live in less deprived areas, have healthier lifestyles and weigh ...

Walk faster! It could make your heart healthier, according to a large new study. The UK study, published this week in the ...

Listed under Table 6A of the proposed rule, the following new diagnostic codes represent the first-ever formal classification of complications specific to the Fontan circulation: ...

Donald Trump again has raised the prospect of a new tariff on imported pharmaceuticals, reportedly pitched at a 25% rate.

EBR designed its WiSE system to significantly expand the population of patients who could benefit from CRT. The leadless ...